INVESTMENT THESIS
A focused thesis. A practical path to market.
ITZA is a women’s-health device fund. Built from Mexico for global markets. Our thesis connects an undercapitalized category with the capabilities needed to bring solutions into the hands of women everywhere.
Women’s health received 6% of private healthcare investment.
Based on 2020–2025 transactions tracked by the Women’s Health Investment Index. This market context informs ITZA’s focus alongside company-specific diligence.
Why devices
Devices can bring new ways to test, monitor, diagnose and treat. They also require an exacting path through evidence, regulation, manufacturing and commercial adoption. ITZA focuses on physical products where investment and practical support can work together.
Capital with infrastructure.
We evaluate the next concrete steps a company needs to take: generate clinical evidence, clarify a regulatory pathway, prepare production or enter a market. The investment case and the operating plan should reinforce each other.
Built from Mexico for global markets.
In 2024, Mexico was the #1 supplier of medical instruments to the US and the #4 exporter worldwide among countries, by trade value. The category covers medical, surgical, dental and veterinary instruments. We assess the specific advantages Mexico can offer each company.
Closing the women’s-health gap could add US$1 trillion annually to the global economy by 2040.
The same research projects around US$3 in global economic growth for every US$1 invested in closing the gap. These are economy-wide scenarios; investment performance is evaluated separately.